Tokio Marine Asset Management Co. Ltd. bought a new position in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) in the third quarter, according to its most recent disclosure with the SEC. The firm bought 4,134 shares of the company’s stock, valued at approximately $301,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. Cromwell Holdings LLC grew its holdings in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the period. Covestor Ltd grew its stake in shares of Henry Schein by 12.8% in the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock valued at $114,000 after buying an additional 171 shares during the period. Simplify Asset Management Inc. increased its holdings in shares of Henry Schein by 5.0% during the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after buying an additional 175 shares during the last quarter. Sequoia Financial Advisors LLC raised its position in shares of Henry Schein by 3.2% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock valued at $364,000 after buying an additional 176 shares during the period. Finally, Studio Investment Management LLC lifted its holdings in Henry Schein by 4.7% in the second quarter. Studio Investment Management LLC now owns 4,502 shares of the company’s stock valued at $289,000 after acquiring an additional 204 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.
Henry Schein Stock Performance
NASDAQ:HSIC opened at $68.76 on Friday. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a fifty day simple moving average of $70.30 and a two-hundred day simple moving average of $69.57. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.57 billion, a price-to-earnings ratio of 28.30, a price-to-earnings-growth ratio of 1.94 and a beta of 0.87.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on HSIC shares. Barrington Research reissued an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI boosted their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. reduced their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. Finally, Robert W. Baird lowered their price objective on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Henry Schein currently has an average rating of “Moderate Buy” and an average target price of $78.89.
Check Out Our Latest Stock Report on HSIC
Insiders Place Their Bets
In other news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares of the company’s stock, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.14% of the stock is currently owned by company insiders.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading
- Five stocks we like better than Henry Schein
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Profitably Trade Stocks at 52-Week Highs
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to invest in marijuana stocks in 7 steps
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.